Related Articles
Stabilization of disease as a useful predictor of survival following second-line chemotherapy in small cell lung cancer and ovarian cancer patients.
Nucleotide excision repair gene polymorphisms and prognosis of non?small cell lung cancer patients receiving platinum?based chemotherapy: A meta?analysis based on 44 studies
Efficacy and safety of camrelizumab (a PD‑1 inhibitor) combined with chemotherapy as a neoadjuvant regimen in patients with locally advanced non‑small cell lung cancer
Efficacy and safety of apatinib plus chemotherapy vs. chemotherapy alone for the treatment of advanced‑stage non‑small cell lung cancer: A meta‑analysis
Similar survival benefits of a good response and stable disease to platinum-based chemotherapy in non-small cell lung cancer